- Home
- CERS vs KRNY Comparison
CERS vs KRNY Comparison
Compare CERS & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- KRNY
- Stock Information
- Founded
- CERS 1991
- KRNY 1884
- Country
- CERS United States
- KRNY United States
- Employees
- CERS N/A
- KRNY 556
- Industry
- CERS EDP Services
- KRNY Savings Institutions
- Sector
- CERS Technology
- KRNY Finance
- Exchange
- CERS Nasdaq
- KRNY Nasdaq
- Market Cap
- CERS 347.3M
- KRNY 381.4M
- IPO Year
- CERS 1997
- KRNY 2005
- Fundamental
- Price
- CERS $1.30
- KRNY $5.92
- Analyst Decision
- CERS Strong Buy
- KRNY Buy
- Analyst Count
- CERS 2
- KRNY 2
- Target Price
- CERS $3.50
- KRNY $7.75
- AVG Volume (30 Days)
- CERS 1.3M
- KRNY 426.3K
- Earning Date
- CERS 05-01-2025
- KRNY 04-24-2025
- Dividend Yield
- CERS N/A
- KRNY 7.56%
- EPS Growth
- CERS N/A
- KRNY N/A
- EPS
- CERS N/A
- KRNY N/A
- Revenue
- CERS $180,270,000.00
- KRNY $148,070,000.00
- Revenue This Year
- CERS $25.57
- KRNY $17.60
- Revenue Next Year
- CERS $10.54
- KRNY $22.31
- P/E Ratio
- CERS N/A
- KRNY N/A
- Revenue Growth
- CERS 15.29
- KRNY N/A
- 52 Week Low
- CERS $1.12
- KRNY $5.28
- 52 Week High
- CERS $2.54
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- CERS 42.68
- KRNY 43.00
- Support Level
- CERS $1.12
- KRNY $5.55
- Resistance Level
- CERS $1.42
- KRNY $5.91
- Average True Range (ATR)
- CERS 0.11
- KRNY 0.29
- MACD
- CERS 0.01
- KRNY 0.01
- Stochastic Oscillator
- CERS 58.06
- KRNY 51.65
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.